Register Log-in Investor Type

Healthcare News

This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term care facilities, and medical equipment and supplies. Companies in this sector include Astra Zeneca, Pfizer and Roche Holding.

30 Oct 2018
International Biotechnology benefits from narrowing discount

International Biotechnology benefits from narrowing discount

International Biotechnology benefits from narrowing discount – International Biotechnology has reported that, over the year ended 31 August 2018, its NAV laggeded the NASDAQ Biotechnology Index (NBI) a little, returning 8.6% versus the NBI return of 10.1%. A narrowing discount meant that shareholders saw a total return of 13.7%, however. The biotech sector outperformed the UK equity market over […]

23 Oct 2018
Caledonia selling Choice Care Group

Caledonia selling Choice Care Group

Caledonia selling Choice Care Group – Caledonia Investments is selling Choice Care Group, a provider of residential and supported living services for people with learning disabilities and mental health conditions, to iCON Infrastructure Partners, IV L.P., a fund advised by iCON Infrastructure LLP, an independent infrastructure investment group with approximately EUR2.5bn of assets under management. Choice was […]

03 Aug 2018

Trust favourite Neurocrine’s shares rise on strong Ingrezza report

Trust favourite Neurocrine’s shares rise on strong Ingrezza report Neurocrine Biosciences (Nasdaq: NBIX),  the US biotech that is the largest single holding for International Biotechnology Trust (IBT, 5.5% of NAV) and second largest for BB Biotech (BBB.S, 8.9% of NAV), has seen its share rise by more than 15% this week on the back of a strong […]

26 Feb 2018

Investment Trust Insider on primary healthcare

James Carthew: doctor your portfolio with a GP landlord Primary Healthcare Properties (PHP) last week announced results for the year to 31 December 2017. It is one of three listed funds investing in GP surgeries and other primary healthcare facilities in the UK and Ireland, the others being MedicX (MXF) and Assura (AGR). Most of […]

03 Jan 2018

Biotech bellwether Celgene to report key update next week

Biotech bellwether Celgene to report key update next week Investors in the main sector specialist investment trusts should watch for an important update from Celgene early next week at the annual JP Morgan Healthcare Conference, the largest and most important investor event in the sector. The US biotech group is expected to “pre-announce” Q4 sales […]

28 Feb 2017

Cash drag holds back earnings at Primary Health Properties

Primary Health Properties says its EPRA NAV per share increased from 87.7p to 91.1p over the course of 2016. The dividend was raised from 5p to 5.125p. The first quarterly dividend of the new year has been set at 1.31pEPRA earnings per share were lower at 4.8p, down from 4.9p on the back of increased […]

11 Sep 2015

Public Service Properties in talks to sell remaining assets

Public Service Properties has reported its interim results for the six months ended 30 June 2015. The NAV at 30 June 2015 was 49.1p. In March 2015 the Company completed the disposal of its investment in the UK healthcare sector with the sale of companies, businesses and assets at a gross sale value of approximately £34.5m […]

23 Mar 2015

Public Service Properties down to handful of German assets

Public Service Properties has announced its results for the year ended 31 December 2014. These have in large measure been superseded by the sale of its UK care home market and ancillary businesses for cash on 4 March 2015 and the sale of three of its German care homes in November 2014 and January 2015. […]

03 Nov 2014

Public Service Properties selling assets in Germany

PSPI : Public Service Properties selling assets in Germany Public Service Properties has announced the sale of two care homes in Langen and Luzerath in Germany leased to Marseille Kliniken AG. They will get €13.4m in cash and will use €10.7m of the proceeds to pay down debt associated with their German investments – reducing the […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…